Market News AIOpen the app

Theriva Biologics will do a 1-for-30 reverse stock split starting December 1, 2026, to meet NYSE rules.

New sharesRead the original at SEC EDGAR
Neutral

Theriva Biologics will combine every 30 shares into 1 to meet NYSE American's share-price rules. The share count changes, but owners generally keep the same proportional stake and the filing reports no change to the business.

TOVX · Theriva Biologics, Inc.

AI read · Neutral

The AI's read

This changes the share count, not the company's products, sales, or cash. Each holder keeps roughly the same ownership share, with fractional holdings rounded up. The company says the change is meant to meet NYSE American's per-share price rules. The filing reports no new operating results or funding.

Get alerts for TOVX

Follow Theriva Biologics, Inc. (TOVX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TOVX
Free on the App Store and Google Play, or on the web.